AAPACN is dedicated to supporting post-acute care nurses provide quality care.

FDA Alert: Risks to Patients Exposed to Xylazine in Illicit Drugs (11/22)

[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its effects. FDA is aware of increasing reports of...

Oops! This is member-only content.

Please login, sign up for a full membership, or sign up for a free 30-day trial membership to access this content.